Muse raises $23M in series B

Genome engineering company Muse Biotechnology Inc. (Boulder, Colo.) said it raised $23 million in an oversubscribed series B round led by Venrock. Foresite Capital and Paladin Capital also participated, as did existing investors NanoDimension and Spruce/MLS. ...